Fadi Jaafar
Podiatrist · Alma, MINPI 1679837504
Payments from drug & device makers
What this record shows
This record is dominated by other: $187,800 of the $191,483 with a category attached, or 98.1%. Skye Orthobiologics LLC accounts for 98.1% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2024 at $187,999 and has fallen 100.0% since, to $37 in 2025. Among podiatrist clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 99 payments — averaging $1934.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Skye Orthobiologics LLC$188K
- Medwest Associates$2K
- Arthrex$428
- Stryker$369
- Amgen$262
- Organogenesis Inc.$200
- plus $772 from 14 others
What the payments were for
- Travel & lodging$1,2251%
- Food & beverage$1,7131%
- Education$7460%
- Other$187,80098%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Skye Orthobiologics LLC | 2 | $187,800 |
| Medwest Associates | 3 | $1,653 |
| Arthrex | 14 | $428 |
| Stryker | 5 | $369 |
| Amgen(2 entities) | 24 | $262 |
| Organogenesis Inc. | 13 | $200 |
| Paratek Pharmaceuticals, Inc. | 11 | $174 |
| Treace Medical Concepts, Inc. | 3 | $148 |
| Smith+Nephew | 7 | $132 |
| Pacira Pharmaceuticals Incorporated | 1 | $75 |
| Orthofix Medical, Inc. | 5 | $66 |
| AbbVie | 3 | $51 |
| Kerecis Limited | 1 | $26 |
| Merck | 1 | $17 |
| Alfasigma USA, Inc. | 1 | $15 |
| Convatec Inc. | 1 | $15 |
| Osteomed LLC | 1 | $15 |
| Heron Therapeutics, Inc. | 1 | $14 |
| Anika Therapeutics, Inc. | 1 | $13 |
| Paragon 28, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Actishield$147
How this compares
$191,483 in reported general payments places this provider in the 95th percentile of 302 podiatrist providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 33 | $553 |
| Cephalexin | 19 | $455 |
| Gabapentin | 15 | $140 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Alma
- Jeffrey KleinLivonia$117K
- Gary RothenbergAnn Arbor$85K
- Randy SemmaCommerce Twp$31K
- Alton JohnsonAnn Arbor$21K
- Krista KotzevaSouthfield$20K
- Darryl MartinsJackson$19K
- Hassan AlkhalilDearborn$18K
- Joshua KazdanSouthfield$18K
- Daniel AronovitzWarren$17K
- Jeffrey LinDewitt$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.